Experience

Grünenthal GmbH v. Teva Pharmaceuticals

Grünenthal GmbH

Teva Pharmaceuticals

Represented Grünenthal in ANDA litigations against several defendants relating to abuse-deterrent formulations of OxyContin®and Opana®.

Grünenthal GmbH v. Teva Pharmaceuticals, 1:12-cv-08060, S.D.N.Y., Judges Griesa, Daniels, Gorenstein

Related Professionals

Anthony C. Tridico, Ph.D.
Partner
Washington, DC
+1 202 408 4173
Email
Jennifer H. Roscetti
Partner
Washington, DC
+1 202 408 4150
Email
Matthew J. Luneack
Partner
Washington, DC
+1 202 408 4436
Email

Related Practices

Global IP Enforcement, Litigation, and Trials

Branded Hatch-Waxman (ANDA) Litigation and Trials

Related Industries

Life Sciences

Pharmaceutical

Related Experiences

Neste Oil Oyj v. Dynamic Fuels, LLC

Neste Oil

Acura Pharmaceuticals v. Sandoz

Acura Pharmaceuticals Incorporated

BTG Int'l Ltd. v. Kappos

BTG International Ltd.

Delavau, LLC, v. J.M. Huber Corporation

J.M. Huber Corp.

Apotex Inc. v. Senju Pharmaceutical

Senju Pharmaceuticals Co. Ltd.

Bridgestone Firestone v. FleetPride

Bridgestone Firestone

Ferring B.V. v. Allergan, Inc.

Ferring B.V.

Settlement achieved for Boeing

The Boeing Company

Shionogi Pharmaceuticals v. Apotex/Sandoz

Shionogi Pharmaceuticals

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.